三友医疗: 第四届董事会第三次会议决议公告

Group 1 - The board of directors of Shanghai Sanyou Medical Instrument Co., Ltd. held its third meeting of the fourth session on August 22, 2025, with all nine directors present, and the meeting was deemed legally valid [1][2]. - The board approved the draft of the 2025 Restricted Stock Incentive Plan, which aims to align the interests of core employees with the long-term development of the company, thereby maximizing value for both the company and its shareholders [2][3]. - The board also approved the implementation assessment management measures for the 2025 Restricted Stock Incentive Plan, ensuring compliance with relevant laws and facilitating the plan's smooth execution [3][4]. Group 2 - The board proposed to seek authorization from the shareholders' meeting to handle matters related to the 2025 Restricted Stock Incentive Plan, including determining eligibility for participants and making necessary adjustments in case of corporate actions [4][5]. - The board's proposal to convene the fourth temporary shareholders' meeting of 2025 was also approved, with details published on the Shanghai Stock Exchange website [5][6].